Use Able AI chat for product recommendations

Recombinant Rat CCL20/MIP-3 alpha protein (rFc Tag)

Species

Rat

Purity

>90 %, SDS-PAGE

Tag

rFc Tag

Activity

not tested

Cat no : Eg3237



Product Information

Purity >90 %, SDS-PAGE
Endotoxin <0.1 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Rat CCL20 protein Ser27-Met96 (Accession# P97884) with a rabbit IgG Fc tag at the C-terminus.
GeneID 29538
Accession P97884
PredictedSize 34.2 kDa
SDS-PAGE 35-40 kDa, reducing (R) conditions
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

CCL20, also known as MIP-3 alpha, is a chemokine expressed mainly in the lymphatic tissue, lung and liver produced by cells related with inflammation and autoimmune response such as endothelial cells, neutrophils, natural killer (NK), Th17 cells and B cells among others. CCL20 contributes to inflammatory cell recruitment. CCL20 selectively signals through its receptor CCR6. The ligand-receptor pair CCL20/CCR6 is responsible for the chemoattraction of immature dendritic cells, effector/memory T cells and B cells, and also serves a role in the skin and mucosal surfaces under homeostatic and inflammatory conditions, as well as in pathological processes, such as those associated with cancer and rheumatoid arthritis.

References:

1. Schutyser, Evemie et al. Cytokine & growth factor reviews vol. 14,5 (2003): 409-26.  2. Hromas, R et al. Blood vol. 89,9 (1997): 3315-22. 3. Shimizu, Y et al. Hepatology (Baltimore, Md.) vol. 34,2 (2001): 311-9. 4. Lee, Adrian Y S et al. Frontiers in immunology vol. 4 (2013): 194.

||
New chat

Able™

正在加载,请稍候...